Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP753929.RAaaNHAWoyQFfOwTfFNOru27GSUVbf2wk872olOn1lDfc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP753929.RAaaNHAWoyQFfOwTfFNOru27GSUVbf2wk872olOn1lDfc130_assertion type Assertion NP753929.RAaaNHAWoyQFfOwTfFNOru27GSUVbf2wk872olOn1lDfc130_head.
- NP753929.RAaaNHAWoyQFfOwTfFNOru27GSUVbf2wk872olOn1lDfc130_assertion description "[Therefore, MCAM can be used not only as a molecular marker to determine the prognosis of ovarian cancer but also as a therapeutic target in metastatic ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP753929.RAaaNHAWoyQFfOwTfFNOru27GSUVbf2wk872olOn1lDfc130_provenance.
- NP753929.RAaaNHAWoyQFfOwTfFNOru27GSUVbf2wk872olOn1lDfc130_assertion evidence source_evidence_literature NP753929.RAaaNHAWoyQFfOwTfFNOru27GSUVbf2wk872olOn1lDfc130_provenance.
- NP753929.RAaaNHAWoyQFfOwTfFNOru27GSUVbf2wk872olOn1lDfc130_assertion SIO_000772 22610942 NP753929.RAaaNHAWoyQFfOwTfFNOru27GSUVbf2wk872olOn1lDfc130_provenance.
- NP753929.RAaaNHAWoyQFfOwTfFNOru27GSUVbf2wk872olOn1lDfc130_assertion wasDerivedFrom befree-20140225 NP753929.RAaaNHAWoyQFfOwTfFNOru27GSUVbf2wk872olOn1lDfc130_provenance.
- NP753929.RAaaNHAWoyQFfOwTfFNOru27GSUVbf2wk872olOn1lDfc130_assertion wasGeneratedBy ECO_0000203 NP753929.RAaaNHAWoyQFfOwTfFNOru27GSUVbf2wk872olOn1lDfc130_provenance.